Trademark: 90533576
Word
VELESSIA
Status
Dead
Status Code
606
Status Date
Monday, July 3, 2023
Serial Number
90533576
Mark Type
4000
Filing Date
Thursday, February 18, 2021
Published for Opposition
Tuesday, April 5, 2022
Abandoned Date
Monday, July 3, 2023

Trademark Owner History
Allergan Sales, LLC - Owner At Publication

Classifications
5 Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction, and breast aesthetic treatment procedures; topical antibiotics, anti-inflammatory, anti-infective, anti-glaucoma agents and decongestant formulations; sterile antibiotic ointments; ocular contact lens wetting solutions, artificial tears and pharmaceutical preparations for the treatment of minor ocular inflammations and allergic conditions; dermatological formulations, namely, medicated dry skin lotions and creams, acne medications and medicated skin lightener lotions and creams; oral, transdermal, injectable and intravaginal contraceptive preparations; intravaginal contraceptive sponge; hormone replacement therapy preparations; pharmaceutical preparations for the prevention of preterm birth or pregnancy; pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; pharmaceutical preparations for the treatment and prevention of iron deficiency and anemia; pharmaceutical preparations for the treatment and prevention of osteoporosis; pharmaceutical preparations for the treatment and prevention of endometriosis; pharmaceutical preparations for the treatment and prevention of symptoms associated with uterine fibroids; iron chelating pharmaceutical preparations; fertility enhancing pharmaceutical preparations; pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; pharmaceutical preparations and medicines for the treatment of sensory organ disorders; pharmaceutical preparations and medicines for the treatment of central nervous system disorders; pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; pharmaceutical preparations and medicines for the treatment of circulatory system disorders; pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; antibiotics; antifungal preparations; antivirals and antiprotozoals; pharmaceutical preparations for the prevention and treatment of bacterial infections; pharmaceutical preparations for the prevention and treatment of diabetes and diabetic neuropathy; pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; pharmaceutical preparations for the prevention and treatment of hypertension; preparations for the prevention and treatment of Alzheimer's disease, dementia, aids-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceutical preparations, namely, antipsychotics; coronary vasodilating agents; pharmaceutical preparations for the treatment of hypothyroidism; pharmaceutical and cosmeceutical preparations for skin care, namely, medicated skin cleansers, toners, moisturizers, rejuvenators, rehydrating creams, and lotions for the face and body

Trademark Events
Jul 3, 2023
Abandonment Notice E-Mailed - No Use Statement Filed
Jul 3, 2023
Abandonment - No Use Statement Filed
Nov 30, 2022
Notice Of Approval Of Extension Request E-Mailed
Nov 28, 2022
Sou Extension 1 Granted
Nov 28, 2022
Sou Extension 1 Filed
Nov 28, 2022
Teas Extension Received
May 31, 2022
Noa E-Mailed - Sou Required From Applicant
Apr 5, 2022
Official Gazette Publication Confirmation E-Mailed
Apr 5, 2022
Published For Opposition
Mar 16, 2022
Notification Of Notice Of Publication E-Mailed
Mar 3, 2022
Approved For Pub - Principal Register
Mar 2, 2022
Teas/Email Correspondence Entered
Mar 2, 2022
Correspondence Received In Law Office
Mar 2, 2022
Teas Response To Office Action Received
Sep 16, 2021
Notification Of Non-Final Action E-Mailed
Sep 16, 2021
Non-Final Action E-Mailed
Sep 16, 2021
Non-Final Action Written
Sep 14, 2021
Assigned To Examiner
May 19, 2021
New Application Office Supplied Data Entered
Feb 22, 2021
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24